The tumor dormancy is described as the equilibrium phase during which tumor cell outgrowth is inhibited by the activity of T cells, IL-12 and IFN-γ, indicating the dominant contribution of adaptive immunity. The gene discussed is IFNG; the disease is neoplasm.